<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141652627607500%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201903007%26RESULT%3d1%26SIGN%3dBdDIBw8bWkbzIYgUv1FY7g2suhg%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201903007&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201903007&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201903007&amp;v=MDQ5ODhIOWpNckk5Rlk0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWcnpQUFRYTVpiRzQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#28" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#29" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#31" data-title="1.2 指标检测方法">1.2 指标检测方法</a></li>
                                                <li><a href="#33" data-title="1.3 观察指标">1.3 观察指标</a></li>
                                                <li><a href="#35" data-title="1.4 统计学方法">1.4 统计学方法</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#38" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#39" data-title="2.1 两组受试者入组时血清galectin-3、PTX-3、NT-ProBNP检测结果比较">2.1 两组受试者入组时血清galectin-3、PTX-3、NT-ProBNP检测结果比较</a></li>
                                                <li><a href="#43" data-title="2.2 两组受试者入组时左室功能指标检测结果比较">2.2 两组受试者入组时左室功能指标检测结果比较</a></li>
                                                <li><a href="#47" data-title="2.3 预后优良组和预后不良组受试者入组时血清galectin-3、PTX-3检测结果比较">2.3 预后优良组和预后不良组受试者入组时血清galectin-3、PTX-3检测结果比较</a></li>
                                                <li><a href="#51" data-title="2.4 血清galectin-3、PTX-3水平与CHF患者不良预后的相关性分析">2.4 血清galectin-3、PTX-3水平与CHF患者不良预后的相关性分析</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#54" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#41" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组血清指标检测结果比较&lt;/b&gt;&lt;mathml id=&quot;42&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo&gt;, &lt;/mo&gt;&lt;mtext&gt;n&lt;/mtext&gt;&lt;mo&gt;=&lt;/mo&gt;&lt;mn&gt;1&lt;/mn&gt;&lt;mn&gt;5&lt;/mn&gt;&lt;mn&gt;0&lt;/mn&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>1 <b>两组血清指标检测结果比较</b><mathml id="42"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>1</mn><mn>5</mn><mn>0</mn><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#45" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;两组左室功能指标检测结果比较&lt;/b&gt;&lt;mathml id=&quot;46&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>2 <b>两组左室功能指标检测结果比较</b><mathml id="46"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#49" data-title="&lt;b&gt;表&lt;/b&gt;3 &lt;b&gt;两组血清&lt;/b&gt;galectin-3、PTX-3&lt;b&gt;检测结果比较&lt;/b&gt;&lt;mathml id=&quot;50&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>3 <b>两组血清</b>galectin-3、PTX-3<b>检测结果比较</b><mathml id="50"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#53" data-title="&lt;b&gt;表&lt;/b&gt;4 &lt;b&gt;患者不良预后的相关性分析&lt;/b&gt;"><b>表</b>4 <b>患者不良预后的相关性分析</b></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="D&#237;az-Toro F, Nazzal NC, Verdejo PH.Incidence and hospital mortality due to heart failure.Are there any differences by sex?[J].Rev Med Chil, 2017, 145 (6) :703-709." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Incidence and hospital mortality due to heart failure.Are there any differences by sex?">
                                        <b>[1]</b>
                                        D&#237;az-Toro F, Nazzal NC, Verdejo PH.Incidence and hospital mortality due to heart failure.Are there any differences by sex?[J].Rev Med Chil, 2017, 145 (6) :703-709.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="Mueller T, Leitner I, Egger M, et al.Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases[J].Clin Chim Acta, 2015, 445:155-60." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15120600541396&amp;v=MTk3NTQvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGNFJhUlU9TmlmT2ZiSzlIOVBNcVk5RlllOE9EM1Uvb0JNVDZUNFBRSA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        Mueller T, Leitner I, Egger M, et al.Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases[J].Clin Chim Acta, 2015, 445:155-60.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="Carbone F, Montecucco F, Rigamonti F.A critical role of Pentraxin 3 in severe sepsis and septic shock[J].Eur J Clin Invest, 2018, 48 (1) :." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=A critical role of Pentraxin 3 in severe sepsis and septic shock">
                                        <b>[3]</b>
                                        Carbone F, Montecucco F, Rigamonti F.A critical role of Pentraxin 3 in severe sepsis and septic shock[J].Eur J Clin Invest, 2018, 48 (1) :.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="Casula M, Montecucco F, Bonaventura A, et al.Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases[J].Vascul Pharmacol, 2017, 99:1-12." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES949A34E48E8F995BE7CE6C914017815A&amp;v=MTI5Mzg3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMaTZ3Njg9TmlmT2ZicThGNkRQcS9wQmJKNEhlblV3eW1SbTdVd0lUZ3pyclJZMWVMV2NSTC91Q09OdkZTaVdXcg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        Casula M, Montecucco F, Bonaventura A, et al.Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases[J].Vascul Pharmacol, 2017, 99:1-12.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="Rossel V, D&#237;az-Toro F, Verdejo H, et al.Galectin-3 levels in patients hospitalized for decompensated heart failure[J].Rev Med Chil, 2017, 145 (6) :734-740." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=[Galectin-3 levels in patients hospitalized for decompensated heart failure]">
                                        <b>[5]</b>
                                        Rossel V, D&#237;az-Toro F, Verdejo H, et al.Galectin-3 levels in patients hospitalized for decompensated heart failure[J].Rev Med Chil, 2017, 145 (6) :734-740.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="王喆.《中国心力衰竭诊断和治疗指南2014》解读[J].中国临床医生杂志, 2016, 44 (05) :14-16." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLYS201605007&amp;v=MjgxMjhadVptRnlqbFZyelBQeUhTZmJHNEg5Zk1xbzlGWTRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                        王喆.《中国心力衰竭诊断和治疗指南2014》解读[J].中国临床医生杂志, 2016, 44 (05) :14-16.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="Mueller M, Giannitsis E, Katus HA.Essential cardiac biomarkers in myocardial infarction and heart failure[J].Herz, 2014, 39 (6) :727-739." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=[Essential cardiac biomarkers in myocardial infarction and heart failure]">
                                        <b>[7]</b>
                                        Mueller M, Giannitsis E, Katus HA.Essential cardiac biomarkers in myocardial infarction and heart failure[J].Herz, 2014, 39 (6) :727-739.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="裕晓玲, 刘振江, 秦玲.血清半乳糖凝集素3水平与慢性心力衰竭及其预后关系的Meta分析[J].吉林大学学报 (医学版) , 2015, 41 (6) :1224-1229." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=BQEB201506024&amp;v=MjA4NDVSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVnJ6UEp6ek9iTEc0SDlUTXFZOUhZSVFLREg4NHY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        裕晓玲, 刘振江, 秦玲.血清半乳糖凝集素3水平与慢性心力衰竭及其预后关系的Meta分析[J].吉林大学学报 (医学版) , 2015, 41 (6) :1224-1229.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="薛寒, 陈小枫, 缪小莉.老年慢性心力衰竭患者血清半乳糖凝集素3、B型脑钠肽水平变化及意义[J].内科急危重症杂志, 2016, 22 (5) :365-366, 395." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=NKJW201605016&amp;v=MDc3NTFNcW85RVlvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWcnpQS3liQmViRzRIOWY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        薛寒, 陈小枫, 缪小莉.老年慢性心力衰竭患者血清半乳糖凝集素3、B型脑钠肽水平变化及意义[J].内科急危重症杂志, 2016, 22 (5) :365-366, 395.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="Gehlken C, Suthahar N, Meijers WC, et al.Galectin-3 in Heart Failure:An Update of the Last 3 Years[J].Heart Fail Clin, 2018, 14 (1) :75-92." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES6BCAB7DAA49F6C74CBB19B2AAA6A2B0B&amp;v=MjY3OTVLeUJKZ21FMThRUTNnM1dORWY4T1dON3J0Q09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeExpNnc2OD1OaWZPZmJYS2JhQytxUHMwRmU4R2VucA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        Gehlken C, Suthahar N, Meijers WC, et al.Galectin-3 in Heart Failure:An Update of the Last 3 Years[J].Heart Fail Clin, 2018, 14 (1) :75-92.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="Guo T, Huang L, Liu C, et al.The clinical value of inflammatory biomarkers in coronary artery disease:PTX3 as a new inflammatory marker[J].Exp Gerontol, 2017, 97:64-67." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJESE9FD0EB96944703BA66EF48C3FA810D7&amp;v=Mjg3NjBXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeExpNnc2OD1OaWZPZmNheGFLWE0ydjFNWXVJTENIczV6R1JpN0RrSVBudnEzeEZEQ0xxVlJjNllDT052RlNpVw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        Guo T, Huang L, Liu C, et al.The clinical value of inflammatory biomarkers in coronary artery disease:PTX3 as a new inflammatory marker[J].Exp Gerontol, 2017, 97:64-67.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(03),289-292 DOI:10.3969/j.issn.1008-0074.2019.03.07            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>慢性心力衰竭患者中血清</b>galectin-3、PTX-3<b>水平的变化及其与预后的关系</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%BC%A0%E6%99%94&amp;code=38485208&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">张晔</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E6%9D%8E%E9%93%B6%E7%A6%8F&amp;code=07801878&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">李银福</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%8F%B2%E9%9B%B7%E5%BF%A0&amp;code=07794355&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">史雷忠</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E7%94%B3%E8%B7%83%E4%BA%91&amp;code=10556774&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">申跃云</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E8%92%8B%E4%BF%8A&amp;code=31968345&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">蒋俊</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%BD%AD%E7%87%95%E9%A3%9E&amp;code=34748368&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">彭燕飞</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%80%AA%E6%82%A6&amp;code=31968342&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">倪悦</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E6%BA%A7%E9%98%B3%E5%B8%82%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E5%BF%83%E8%A1%80%E7%AE%A1%E5%86%85%E7%A7%91&amp;code=0249577&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">溧阳市人民医院心血管内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:探讨慢性心力衰竭 (CHF) 患者血清半乳糖凝聚素-3 (galectin-3) 、正五聚体蛋白-3 (PTX-3) 水平的变化及其与预后的关系。<b>方法</b>:选择2015年1月-12月于我院就诊的150例CHF患者 (CHF组) 和同期体检的150例健康志愿者 (健康组) 为受试对象。比较两组受试者入组时血清galectin-3、PTX-3和N末端B型钠尿肽 (NT-proBNP) 水平及左房内径 (LAD) 、左室舒张末期内径 (LVEDd) 、左室重量指数 (LVMI) 检测结果。随访1年CHF组 (失访12例) , 余被分为预后不良组 (36例) 和预后优良组 (102例) , 比较两亚组入组时血清galectin-3、PTX-3水平。采用Spearman线性相关分析法分析血清galectin-3、PTX-3水平与CHF患者不良预后的相关性。<b>结果</b>:与健康组比较, CHF组入组时血清galectin-3[ (2.23±0.25) ng/ml比 (16.61±1.48) ng/ml]、PTX-3 [ (1.28±0.54) μg/L比 (3.58±0.52) μg/L]、NT-proBNP[ ( (223.23±76.28) pg/ml比952.75±85.43) pg/ml]水平及LAD、LVEDd、LVMI) 水平均明显升高, <i>P</i>均=0.001。与预后优良组比较, 预后不良组血清galectin-3[ (18.52±1.91) ng/ml比 (24.63±2.26) ng/ml]、PTX-3[ (2.65±0.74) μg/L比 (3.95±1.05) μg/L]水平显著升高, <i>P</i>均=0.001。Spearman线性相关分析法显示, 血清galectin-3、PTX-3水平与CHF患者主要心脏不良事件呈显著正相关 (<i>r</i>=0.608, 0.558, <i>P</i>均=0.001) 。<b>结论</b>:CHF患者galectin-3、PTX-3、NT-proBNP水平显著升高, 且与CHF患者预后关系密切, 可作为预测预后的辅助指标, 为针对性治疗方案的制定提供依据。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E5%8A%9B%E8%A1%B0%E7%AB%AD&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心力衰竭;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%8D%8A%E4%B9%B3%E7%B3%96%E5%87%9D%E8%81%9A%E7%B4%A03&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">半乳糖凝聚素3;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E9%A2%84%E5%90%8E&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">预后;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                            <b>作者简介：</b>
                                                        <span>
                                    *李银福, E-mail:393273239@qq.com;
                                </span>
                    </p>
                                    <p><b>收稿日期：</b>2018-01-04</p>

                    <p>

                            <b>基金：</b>
                                                        <span>江苏大学2014年度医学临床科技发展基金项目 (JLY20140094);</span>
                                <span>溧阳市重点研发计划 (社会发展) 项目 (LC2015009);</span>
                    </p>
            </div>
                    <h1>Changes of serum galectin-3 and pentraxin-3 levels in CHF patients and their correlation with prognosis</h1>
                    <h2>
                    <span>ZHANG Ye</span>
                    <span>LI Yin-fu</span>
                    <span>SHI Lei-zhong</span>
                    <span>SHEN Yue-yun</span>
                    <span>JIANG Jun</span>
                    <span>PENG Yan-fei</span>
                    <span>NI Yue</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, People′s Hospital of Liyang City</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>: To explore changes of serum levels of galectin-3 and pentraxin-3 (PTX-3) in patients with chronic heart failure (CHF) and their correlation with prognosis. <b>Methods</b>:A total of 150 CHF patients (CHF group) treated in our hospital and 150 healthy volunteers undergoing physical examination simultaneously (healthy group) from Jan 2015 to Dec 2015 were enrolled. Serum levels of galectin-3, PTX-3 and N-terminal pro brain natriuretic peptide (NT-proBNP) , left atrial diameter (LAD) , left ventricular end-diastolic dimension (LVEDd) and left ventricular mass index (LVMI) were compared between two groups at enrollment. According to one-year follow-up outcome, CHF group (12 cases lost, another 138 cases) was divided into poor prognosis group (n=36) and good prognosis group (n=102) . Spearman linear correlation analysis was used to analyze correlation among serum galectin-3, PTX-3 levels and poor prognosis of CHF patients. <b>Results</b>: Compared with healthy group, there were significant rise in serum levels of galectin-3[ (2.23± 0.25) ng/ml vs. (16.61±1.48) ng/ml], PTX-3 [ (1.28±0.54) μg/L vs. (3.58±0.52) μg/L], NT-proBNP [ (223.23±76.28) pg/ml vs. (952.75±85.43) pg/ml], LAD, LVEDd and LVMI in CHF group, <i>P</i>=0.001 all. Compared with good prognosis group at enrollment, there were significant rise in serum levels of galectin-3 [ (18.52±1.91) ng/ml vs. (24.63±2.26) ng/ml]and PTX-3[ (2.65± 0.74) μg/L vs. (3.95±1.05) μg/L]in poor prognosis group, <i>P</i>=0.001 both.Spearman linear correlation analysis indicated that serum galectin-3 and PTX-3 levels were significant positively correlated with major adverse cardiovascular events in CHF patients (<i>r</i>=0.608, 0.558, <i>P</i>=0.001 both) . <b>Conclusion</b>: Serum levels of galectin-3, PTX-3 and NT-proBNP levels are significant rise and closely related to prognosis of CHF patients, can be used as auxiliary indexes predicting prognosis and may provide the basis for formulation of target therapy.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Heart%20failure&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Heart failure;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Galectin%203&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Galectin 3;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Prognosis&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Prognosis;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                            <b>Author：</b>
                                                        <span>
                                    LI Yin-fu, E-mail:393273239@qq.com;
                                </span>
                    </p>
                                    <p><b>Received：</b> 2018-01-04</p>
                                    <p>
                            <b>Fund：</b>
                                                        <span>The 2014Jiangsu University Medical Clinical Technology Development Fund Project (JLY20140094);</span>
                                <span>Liyang City Key Research and Development Program (Social Development) Project (LC2015009);</span>
                    </p>
            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="27">随着生活结构的改变和生活节奏的加快, 慢性心力衰竭 (CHF) 的发病率在全球范围内急剧上升, 并具有较高死亡率, 尤其成为老年人住院和死亡的主要原因之一<citation id="59" type="reference"><link href="5" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。目前临床用于诊断CHF及评估患者预后状态的标志物日益增多, 半乳糖凝聚素-3 (galectin-3) 是近年受到关注的CHF生物学标志物之一, 能诱导心肌成纤维细胞增殖, 胶原沉积, 参与心肌纤维化及炎症反应等心力衰竭的许多病理生理机制<citation id="60" type="reference"><link href="7" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。而正五聚体蛋白-3 (PTX-3) 作为一种源于心脏及血管损伤组织的, 主要在炎性细胞因子刺激下产生, 能反映机体炎症状态<citation id="61" type="reference"><link href="9" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>。虽然临床有部分研究发现galectin-3、PTX-3在心血管疾病中可见高表达<citation id="62" type="reference"><link href="11" rel="bibliography" /><link href="13" rel="bibliography" /><sup>[<a class="sup">4</a>,<a class="sup">5</a>]</sup></citation>, 但其是否同CHF患者的发病和预后关系密切仍缺乏大量数据验证。本研究为进一步探讨血清galectin-3、PTX-3水平在CHF患者中的表达及对预后的影响。</p>
                </div>
                <h3 id="28" name="28" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="29" name="29">1.1 一般资料</h4>
                <div class="p1">
                    <p id="30">选择2015年1月～2015年12月在我院就诊的150例CHF患者 (CHF组) 和同期体检的150例健康志愿者 (健康组) 为受试对象。排除:①合并其他严重器质性病变、精神疾病、意识障碍、自身免疫性疾病、重要脏器功能障碍或恶性肿瘤者;②临床资料不全者;③年龄不足18岁或超过80岁者;④孕期或哺乳期妇女;⑤不能配合检查或超声检查禁忌症者。CHF组患者经临床专家及影像检查确诊, 符合《中国心力衰竭诊断和治疗指南 (2014版) 》<citation id="63" type="reference"><link href="15" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>中CHF相关诊断标准, 男、女比例为1.03:1 (76/74) ;平均年龄 (63.4±8.6) 岁;根据纽约心脏病协会 (NYHA) 分级:Ⅱ级28例 (18.7%) , Ⅲ级84例 (56.0%) , Ⅳ级38例 (25.3%) 。健康组男、女比例为1.05:1 (82/78) ;平均年龄 (62.3±7.6) 岁。两组受试者年龄、性别等一般资料比较, 差异无显著性 (<i>P</i>&gt;0.05) , 具有可比性。</p>
                </div>
                <h4 class="anchor-tag" id="31" name="31">1.2 指标检测方法</h4>
                <div class="p1">
                    <p id="32">两组受试者入组时均常规采集晨起空腹外周静脉血5ml, 3500r/min下离心15min, 取上层清液置于-20℃冰箱待检;参考人半乳糖凝集素3 (Galectin3) 试剂盒 (由上海基免生物技术有限公司提供) 使用说明书, 经双抗夹心酶联免疫吸附法 (ELISA) 检测血清Galectin3水平;参考人正五聚蛋白-3 (PTX-3) 试剂盒 (由上海基免生物技术有限公司提供) 及人N末端B型钠尿肽 (NT-ProBNP) 试剂盒 (由上海心语生物技术有限公司提供) 使用说明书, 经ELISA法检测血清PTX-3、NT-ProBNP水平。采血后使用Apogee 3100型全数字彩色多普勒超声诊断仪行超声心动图检查, 记录左房内径 (LAD) 、左室舒张末期内径 (LVEDd) 、左室后壁厚度 (LVPWT) 、室间隔厚度 (IVST) 等左室功能指标检测结果, 按照Devereux校正公式计算左室重量指数 (LVMI) :LVMI={1.04× (LVEDd+LVPWT+IVST) <sup>3</sup>-LVEDd<sup>3</sup>]-13.6}/体表面积 (BSA) 。</p>
                </div>
                <h4 class="anchor-tag" id="33" name="33">1.3 观察指标</h4>
                <div class="p1">
                    <p id="34">观察比较两组受试者入组时血清galectin-3、PTX-3、NT-ProBNP水平及左室功能指标 (LAD、LVEDd、LVMI) 检测结果。随访1年, 将随访期主要心脏不良事件 (主要包括心绞痛、急性心肌梗死、严重心律失常、心力衰竭、死亡) 纳入预后不良组, 其他患者纳入预后优良组, 比较两亚组受试者入组时血清galectin-3、PTX-3检测结果差异, 经Spearman线性相关分析法分析血清galectin-3、PTX-3与CHF患者不良预后 (再发心脏事件或死亡) 的关系。</p>
                </div>
                <h4 class="anchor-tag" id="35" name="35">1.4 统计学方法</h4>
                <div class="p1">
                    <p id="36">采用统计学软件SPSS19.0中进行分析, 计量资料以均数±标准差<mathml id="37"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml>表示, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。血清galectin-3、PTX-3水平与CHF患者不良预后的相关性采用Spearman线性相关分析法分析, <i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="38" name="38" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="39" name="39">2.1 两组受试者入组时血清galectin-3、PTX-3、NT-ProBNP检测结果比较</h4>
                <div class="p1">
                    <p id="40">CHF组入组时血清galectin-3、PTX-3、NT-ProBNP检测结果均显著高于健康组, 差异均有显著性 (<i>P</i>均=0.001) , 见表1。</p>
                </div>
                <div class="area_img" id="41">
                    <p class="img_tit"><b>表</b>1 <b>两组血清指标检测结果比较</b><mathml id="42"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>1</mn><mn>5</mn><mn>0</mn><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="41" border="1"><tr><td><br />组别</td><td>galectin-3<br /> (ng/ml) </td><td>PTX-3<br /> (μg/L) </td><td>NT-ProBNP<br /> (pg/ml) </td></tr><tr><td><br />CHF组</td><td>16.61±<br />1.48<sup>△△</sup></td><td>3.58±<br />0.52<sup>△△</sup></td><td>952.75±<br />85.43<sup>△△</sup></td></tr><tr><td><br />健康组</td><td>2.23±<br />0.25</td><td>1.28±<br />0.54</td><td>223.23±<br />76.28</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>117.33/0.001</td><td>37.58/0.001</td><td>78.01/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:galectin-3:半乳糖凝聚素-3, PTX-3:正五聚体蛋白-3, CHF:慢性心力衰竭, NT-ProBNP:N末端B型钠尿肽。与健康组对比, △<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="43" name="43">2.2 两组受试者入组时左室功能指标检测结果比较</h4>
                <div class="p1">
                    <p id="44">CHF组入组时LAD、LVEDd、LVMI检测结果均显著高于健康组, 差异均有显著性 (<i>P</i>均=0.001) , 见表2。</p>
                </div>
                <div class="area_img" id="45">
                    <p class="img_tit"><b>表</b>2 <b>两组左室功能指标检测结果比较</b><mathml id="46"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="45" border="1"><tr><td><br />组别</td><td>左房内径<br /> (mm) </td><td>左室舒张末期内径<br /> (mm) </td><td>左室重量指数<br /> (g/m<sup>2</sup>) </td></tr><tr><td><br />CHF组 (150例) </td><td>48.1±4.4<sup>△△</sup></td><td>51.3±3.7<sup>△△</sup></td><td>137.3±8.3<sup>△△</sup></td></tr><tr><td><br />健康组 (150例) </td><td>32.8±2.4</td><td>38.6±3.1</td><td>92.6±5.9</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>37.38/0.001</td><td>32.22/0.001</td><td>53.76/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="47" name="47">2.3 预后优良组和预后不良组受试者入组时血清galectin-3、PTX-3检测结果比较</h4>
                <div class="p1">
                    <p id="48">随访1年间, CHF组共失访12例患者, 失访率为8.0% (12/150) ;剩余138例患者被纳入预后优良组102例, 纳入预后不良组36例 (其中住院死亡8例, 其余心脏事件28例) 。预后优良组入组时血清galectin-3、PTX-3检测结果均显著低于预后不良组, 差异均有显著性 (<i>P</i>均=0.001) , 见表3。</p>
                </div>
                <div class="area_img" id="49">
                    <p class="img_tit"><b>表</b>3 <b>两组血清</b>galectin-3、PTX-3<b>检测结果比较</b><mathml id="50"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="49" border="1"><tr><td><br />组别</td><td>galectin-3<br /> (ng/ml) </td><td>PTX-3<br /> (μg/L) </td></tr><tr><td><br />预后优良组 (102例) </td><td>18.52±1.91<sup>▲▲</sup></td><td>2.65±0.74<sup>▲▲</sup></td></tr><tr><td><br />预后不良组 (36例) </td><td>24.63±2.26</td><td>3.95±1.05</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>15.71/0.001</td><td>8.07/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与预后不良组比较▲<i>P</i>&lt;0.05, ▲▲<i>P</i>&lt;0.01。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="51" name="51">2.4 血清galectin-3、PTX-3水平与CHF患者不良预后的相关性分析</h4>
                <div class="p1">
                    <p id="52">Spearman线性相关分析法分析结果显示, 血清galectin-3、PTX-3水平与CHF患者主要心脏不良事件呈正相关性 (<i>P</i>均=0.001) , 见表4。</p>
                </div>
                <div class="area_img" id="53">
                    <p class="img_tit"><b>表</b>4 <b>患者不良预后的相关性分析</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="53" border="1"><tr><td><br /></td><td>galectin-3</td><td>PTX-3</td></tr><tr><td><br /><i>r</i></td><td>0.608</td><td>0.558</td></tr><tr><td><br /><i>P</i></td><td>0.001</td><td>0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h3 id="54" name="54" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="55">随着临床研究的深入, 越来越多学者将研究重点向CHF的生物标志物方向转移, BNP 和 NT-proBNP 做为心肌容量负荷指标, ACC/AHC、ESC 和中国心衰指南均肯定了其对心力衰竭的诊断价值。但是 BNP 和 NT-proBNP 水平受很多因素影响, 故越来越多学者将研究重点集中于其他生物标志物的探寻工作上<citation id="64" type="reference"><link href="17" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>。试图以此为临床早期诊断、鉴别诊断及预后危险度分层提供依据, 为更多患者获得理想的针对性治疗措施提供条件。</p>
                </div>
                <div class="p1">
                    <p id="56">国内外研究结果显示, galectin-3也称作巨噬细胞表面抗原-2、碳水化合物结合蛋白-35, 是半乳凝集素家族的一员, 是由活化的巨噬细胞产生的一种糖结合蛋白, 可分布于细胞核和细胞质内, 不仅参与肿瘤细胞的黏附、增殖、分化和转移等过程, 也同CHF的发生、发展关系密切。裕晓玲等学者认为, galectin-3具有加快心肌成纤维细胞增殖、分化进程的作用, 可参与到CHF的多项病理生理机制 (如炎症反应、心肌纤维化等) 中, 将其用于CHF的病情评估及疾病诊断工作中有一定可行性<citation id="65" type="reference"><link href="19" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>。本研究也就此展开分析, 发现确诊CHF的CHF组患者存在血清galectin-3水平显著升高表现, 可能与galectin-3具有活化巨噬细胞、加快胶原合成、沉积速度及促进成纤维细胞增殖的作用相关, 其亦能缩短心室重构进程, 对于患者预后恢复不利。薛寒等学者也在报道中指出, galectin-3能独立于其他已知的危险因素预测CHF患者左室重构状态, 且检测结果同其心衰程度和心功能状态关系密切, 病情越严重、再发心血管事件风险越高者血清galectin-3表达越高<citation id="66" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>。本研究也得到类似结论, 发现血清galectin-3水平和CHF患者的不良预后呈正相关性, 这可能与galectin-3能诱导巨噬细胞浸润心脏组织并活化纤维母细胞, 促心肌纤维化形成相关<citation id="67" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>, 建议就诊时血清galectin-3水平较高者时刻关注病情发展情况, 积极配合治疗、定期复诊, 使医师掌握其疾病发展动向, 及时调整治疗措施、降低再发心血管事件风险。</p>
                </div>
                <div class="p1">
                    <p id="57">PTX-3则是一种新型的炎症因子, 与以C反应蛋白为代表的传统短五聚体蛋白属同一超家族, 主要是由多种组织细胞如单核巨噬细胞、血管内皮细胞、血管平滑肌细胞等在受到炎症刺激因子刺激后产生, 与C反应蛋白具有不同的生物学特性。国外研究发现, PTX-3可参与到主要炎症信号传导通路中, 通过抑制促纤维细胞生长因子水平、促使内皮组织因子表达上调等途径, 达到增强炎症反应程度, 从而加速CHF患者病情发展, 这是最近临床发现的慢性心衰的新的标志物<citation id="68" type="reference"><link href="25" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>。本研究亦发现CHF患者入组时血清PTX-3水平较高, 且与其不良预后呈正相关, 可能与PTX-3有促炎效应, 入组时血清PTX-3水平越高者更易因炎症反应严重而推动病情发展, 致再发心血管事件发生。</p>
                </div>
                <div class="p1">
                    <p id="58">综上所述, 慢性心衰患者存在左室功能指标及血清galectin-3、PTX-3、NT-ProBNP水平异常表现, 需引起重视;血清galectin-3、PTX-3水平与CHF患者MACE事件密切相关, 临床可将其作为预测患者预后的辅助指标, 为针对性治疗方案的拟定提供依据。本研究虽取得一定成果, 但仍有部分结论存在深入探究空间, 可扩大样本量并尽可能排除相关干扰因素后将其作为后续研究课题展开深入分析, 以此获得更严谨、科学的报道结果。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Incidence and hospital mortality due to heart failure.Are there any differences by sex?">

                                <b>[1]</b>Díaz-Toro F, Nazzal NC, Verdejo PH.Incidence and hospital mortality due to heart failure.Are there any differences by sex?[J].Rev Med Chil, 2017, 145 (6) :703-709.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15120600541396&amp;v=MzA2NDhaZVp0RmlubFVyZklJRjRSYVJVPU5pZk9mYks5SDlQTXFZOUZZZThPRDNVL29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1udw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>Mueller T, Leitner I, Egger M, et al.Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases[J].Clin Chim Acta, 2015, 445:155-60.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="http://scholar.cnki.net/result.aspx?q=A critical role of Pentraxin 3 in severe sepsis and septic shock">

                                <b>[3]</b>Carbone F, Montecucco F, Rigamonti F.A critical role of Pentraxin 3 in severe sepsis and septic shock[J].Eur J Clin Invest, 2018, 48 (1) :.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES949A34E48E8F995BE7CE6C914017815A&amp;v=MTk4NTdMVTA1dEJoeExpNnc2OD1OaWZPZmJxOEY2RFBxL3BCYko0SGVuVXd5bVJtN1V3SVRnenJyUlkxZUxXY1JML3VDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCcg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>Casula M, Montecucco F, Bonaventura A, et al.Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases[J].Vascul Pharmacol, 2017, 99:1-12.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="http://scholar.cnki.net/result.aspx?q=[Galectin-3 levels in patients hospitalized for decompensated heart failure]">

                                <b>[5]</b>Rossel V, Díaz-Toro F, Verdejo H, et al.Galectin-3 levels in patients hospitalized for decompensated heart failure[J].Rev Med Chil, 2017, 145 (6) :734-740.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLYS201605007&amp;v=MjkzMjU3cWZadVptRnlqbFZyelBQeUhTZmJHNEg5Zk1xbzlGWTRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b>王喆.《中国心力衰竭诊断和治疗指南2014》解读[J].中国临床医生杂志, 2016, 44 (05) :14-16.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="http://scholar.cnki.net/result.aspx?q=[Essential cardiac biomarkers in myocardial infarction and heart failure]">

                                <b>[7]</b>Mueller M, Giannitsis E, Katus HA.Essential cardiac biomarkers in myocardial infarction and heart failure[J].Herz, 2014, 39 (6) :727-739.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=BQEB201506024&amp;v=MDQyNzFNcVk5SFlJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWcnpQSnp6T2JMRzRIOVQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>裕晓玲, 刘振江, 秦玲.血清半乳糖凝集素3水平与慢性心力衰竭及其预后关系的Meta分析[J].吉林大学学报 (医学版) , 2015, 41 (6) :1224-1229.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=NKJW201605016&amp;v=MTk3MDM0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWcnpQS3liQmViRzRIOWZNcW85RVlvUUtESDg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>薛寒, 陈小枫, 缪小莉.老年慢性心力衰竭患者血清半乳糖凝集素3、B型脑钠肽水平变化及意义[J].内科急危重症杂志, 2016, 22 (5) :365-366, 395.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES6BCAB7DAA49F6C74CBB19B2AAA6A2B0B&amp;v=MjMxMTVLeUJKZ21FMThRUTNnM1dORWY4T1dON3J0Q09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeExpNnc2OD1OaWZPZmJYS2JhQytxUHMwRmU4R2VucA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>Gehlken C, Suthahar N, Meijers WC, et al.Galectin-3 in Heart Failure:An Update of the Last 3 Years[J].Heart Fail Clin, 2018, 14 (1) :75-92.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJESE9FD0EB96944703BA66EF48C3FA810D7&amp;v=MDY0NTZZdUlMQ0hzNXpHUmk3RGtJUG52cTN4RkRDTHFWUmM2WUNPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMaTZ3Njg9TmlmT2ZjYXhhS1hNMnYxTQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>Guo T, Huang L, Liu C, et al.The clinical value of inflammatory biomarkers in coronary artery disease:PTX3 as a new inflammatory marker[J].Exp Gerontol, 2017, 97:64-67.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201903007" />
        <input id="dpi" type="hidden" value="200" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201903007&amp;v=MDQ5ODhIOWpNckk5Rlk0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWcnpQUFRYTVpiRzQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
